Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
CFI Peptide BS5716P
Product NameCFI Peptide
Catalog No.BS5716P
ApplicationsBlocking
Swiss-ProtP05156
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide CFI. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS5716 CFI pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
CFI Peptide
Applications :
Blocking
Background :
The complement pathway is an important host defense system that contributes to both innate and acquired immunity. There are three pathways of complement activation: the classical pathway, lectin pathway and alternative pathway. Complement protein Factor I is a key serine protease that modulates the complement cascade by regulating the levels of C3 convertases. It circulates in plasma as a heavily N-glycosylated heterodimer made up of two disulfide linked chains, each carrying three N-linked oligosaccharide chains that may have both structural and functional roles in the interactions with the natural substrate and the cofactor during catalysis. Factor I is a serine protease with a high degree of specificity for C3b and C4b. It requires protein cofactors for cleavage of these complement proteins; Factor H, CR1 or MCP are required for C3b cleavage, and C4bp or CR1 are required for C4b cleavage.
Alternative Name :
Complement factor I; C3B/C4B inactivator; Complement factor I heavy chain; IF
Swiss-Prot :
P05156
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide CFI. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS5716 CFI pAb.
Blocking peptide available as BS5716PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER